LPA and metabolic syndrome: In their analysis, the prevalence of dyslipidemia was around 1.7 times greater in the high-Lp(a) group (>100 mg/dL) compared to the moderate (50–100 mg/dL)- and low (<50 mg/dL)-Lp(a) groups, but the prevalence of dyslipidemia in this population was generally low (27.3–46.5%).